ORIC

Oric Pharmaceuticals, Inc.

• TipRanks·2d ago

  JonesTrading Sticks to Their Buy Rating for Oric Pharmaceuticals (ORIC)

• Simply Wall St·3d ago

  A Look At ORIC Pharmaceuticals (ORIC) Valuation After Advancing Rinzimetostat To A Phase 3 Prostate Cancer Trial

• Reuters·5d ago

  Oric Pharma grants 80,000 stock options in Nasdaq Rule 5635(c)(4) inducement award

• Simply Wall St·5d ago

  ORIC Pharmaceuticals (ORIC) Is Down 28.2% After Selecting 400 mg Rinzimetostat Dose for Phase 3

• TipRanks·6d ago

  3 Best Stocks to Buy amid the Market Pullback, According to Top Analysts

• Dow Jones·6d ago

  Oric Pharmaceuticals Price Target Maintained With a $25.00/Share by HC Wainwright & Co.

• Benzinga·6d ago

  HC Wainwright & Co. Reiterates Buy on ORIC Pharmaceuticals, Maintains $25 Price Target

• TipRanks·6d ago

  Analysts Offer Insights on Healthcare Companies: Imunon (IMNN), Axsome Therapeutics (AXSM) and Oric Pharmaceuticals (ORIC)

• TipRanks·6d ago

  Oric selloff brings attractive entry point, says H.C. Wainwright

• NASDAQ·04/01 22:23

  Stocks Settle Higher on Hopes for Conclusion to Iran War

• The Wall Street Journal·04/01 20:05

  Oric Shares Fall 40% as Cancer-Drug Data Falls Short of Expectations

• Dow Jones·04/01 19:24

  Oric Pharmaceuticals Down Nearly 39%, on Track for Record Percent Decrease -- Data Talk

• TipRanks·04/01 17:40

  Analysts Are Bullish on Top Healthcare Stocks: Oric Pharmaceuticals (ORIC), Inmune Bio (INMB)

• TipRanks·04/01 17:37

  Oric Pharmaceuticals should be bought on selloff, says Citi

• Seeking Alpha·04/01 17:14

  ORIC Pharmaceuticals: Updates Did Not Bode Well For This Valuation